NAMSA Executive and Leadership Team

Scott Sellick, the Chief Financial Officer at NAMSA, directs all fiscal planning and capital allocation strategies. Managing the financial health of the organization, the Chief Financial Officer oversees budgeting, forecasting, and long-term investment initiatives to support the expansion of medical research capabilities. By optimizing resource distribution across North American and international operations, Sellick ensures the company maintains the necessary liquidity to fund complex clinical research projects. This leadership role involves close collaboration with the Board to monitor economic trends impacting the medical device sector. Scott Sellick drives fiscal discipline, ensuring that every investment aligns with the broader mission of accelerating product development. Through rigorous financial oversight, the Chief Financial Officer secures the stability required for sustained growth in the competitive MRO landscape, ultimately enabling the firm to provide high-value consulting services to global clients.

Elizabeth Kempen, the Chief Operating Officer at NAMSA, manages the daily execution of integrated laboratory and clinical research services. Overseeing the operational infrastructure, the Chief Operating Officer ensures that all service delivery models meet stringent regulatory standards while maintaining high efficiency. By streamlining workflows across global facilities, Kempen drives operational excellence and reduces time-to-market for medical device clients. This leadership role requires constant coordination with technical teams to integrate laboratory findings with clinical research data. Elizabeth Kempen monitors performance metrics to identify bottlenecks, implementing process improvements that enhance service quality. Through the management of cross-functional teams, the Chief Operating Officer maintains the operational agility necessary to navigate complex regulatory environments. Kempen ensures that the organization consistently delivers superior results, supporting the overarching goal of advancing medical technology through precise, reliable, and scalable research operations.

Gina Skolmowski, the Global Division President, Laboratory Services at NAMSA, manages the technical operations and service delivery of the laboratory division. Overseeing the testing facilities and analytical capabilities, the Global Division President, Laboratory Services ensures that all laboratory processes meet global regulatory requirements. By directing the implementation of advanced testing technologies, Skolmowski enhances the precision and speed of medical device evaluation. This leadership role involves managing the laboratory workforce and ensuring that technical teams remain aligned with the broader clinical research objectives. Gina Skolmowski monitors quality control protocols to maintain the highest standards of accuracy in all laboratory outputs. Through the optimization of laboratory workflows, the Global Division President, Laboratory Services drives operational efficiency and supports the rapid advancement of client projects. Skolmowski ensures that the laboratory division remains a cornerstone of the company's integrated service model, providing the essential data required for successful medical device development.

Roseanne Sawyer, the Chief Human Resources Officer at NAMSA, architects the talent acquisition and organizational development strategies. Directing the recruitment of specialized scientific and regulatory experts, the Chief Human Resources Officer fosters a culture of innovation and technical excellence. By implementing comprehensive training programs, Sawyer ensures that the workforce remains at the forefront of medical device research methodologies. This leadership role involves aligning human capital initiatives with the company's strategic growth objectives, ensuring that the right expertise supports every clinical and laboratory project. Roseanne Sawyer manages performance management systems and employee engagement programs to retain top-tier talent across global operations. Through the development of robust leadership pipelines, the Chief Human Resources Officer strengthens the organizational foundation. Sawyer drives initiatives that promote professional growth, ensuring that the firm maintains the specialized knowledge base required to serve the complex needs of the medical device industry.

Andrew Suri, the Lead Business Development Executive & Chief Revenue Officer at NAMSA, drives the expansion of the client portfolio through strategic market engagement. Overseeing the acquisition of new partnerships, the Lead Business Development Executive & Chief Revenue Officer focuses on securing long-term contracts with medical device manufacturers. By identifying emerging market opportunities, Suri aligns service offerings with the specific needs of innovators in the clinical research space. This leadership role involves managing high-level client relationships and coordinating with the sales team to maximize revenue growth. Andrew Suri executes outreach strategies that highlight the value of integrated laboratory and regulatory consulting services. Through the analysis of market trends, the Lead Business Development Executive & Chief Revenue Officer ensures that the company remains a preferred partner for complex product development projects. Suri drives revenue performance, ensuring that the organization achieves its financial targets while expanding its footprint in the global healthcare market.

Alexa Liantonio, the Senior Global Business Development Executive & Chief Revenue Officer at NAMSA, manages international growth initiatives and cross-border revenue streams. Directing the expansion of the service footprint into new geographic regions, the Senior Global Business Development Executive & Chief Revenue Officer identifies key opportunities for scaling laboratory and regulatory consulting services. By building alliances with global medical device firms, Liantonio ensures that the company maintains a strong competitive position in international markets. This leadership role involves tailoring business development strategies to meet the unique regulatory and clinical requirements of diverse healthcare systems. Alexa Liantonio coordinates with regional teams to drive market penetration and increase the adoption of integrated research solutions. Through the implementation of targeted growth campaigns, the Senior Global Business Development Executive & Chief Revenue Officer secures sustainable revenue streams. Liantonio drives global market presence, ensuring that the firm remains a leader in accelerating medical device development worldwide.

Adam Saltman, the Chief Medical Officer, At Namsa at NAMSA, provides clinical leadership and scientific oversight for all research programs. Directing the medical strategy, the Chief Medical Officer, At Namsa ensures that clinical trials and laboratory studies adhere to the highest standards of patient safety and scientific integrity. By evaluating the clinical efficacy of medical devices, Saltman guides the development process from initial concept to regulatory approval. This leadership role involves advising clients on complex medical issues and interpreting clinical data to support regulatory submissions. Adam Saltman collaborates with internal research teams to ensure that every project benefits from deep medical expertise. Through the application of rigorous clinical standards, the Chief Medical Officer, At Namsa maintains the credibility of the research organization. Saltman drives scientific excellence, ensuring that the firm provides the medical insights necessary to navigate the challenging path of medical device commercialization and regulatory compliance.